Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2

BACKGROUND: The ongoing COVID-19 pandemic has resulted in 185 million recorded cases and over 4 million deaths worldwide. Several COVID-19 vaccines have been approved for emergency use in humans and are being used in many countries. However, all the approved vaccines are administered by intramuscula...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Huibi, Mai, Juntao, Zhou, Zhichang, Li, Zhijie, Duan, Rongqi, Watt, Jacqueline, Chen, Ziyan, Bandara, Ranmal Avinash, Li, Ming, Ahn, Sang Kyun, Poon, Betty, Christie-Holmes, Natasha, Gray-Owen, Scott D., Banerjee, Arinjay, Mossman, Karen, Kozak, Rob, Mubareka, Samira, Rini, James M., Hu, Jim, Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653804/
https://www.ncbi.nlm.nih.gov/pubmed/34879865
http://dx.doi.org/10.1186/s13578-021-00723-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653804/
https://www.ncbi.nlm.nih.gov/pubmed/34879865
http://dx.doi.org/10.1186/s13578-021-00723-0

Ejemplares similares